Ticagrelor Tablets IP 90 Mg – TEROLINT Tablets

TEROLINT Tablets – Next-Gen Antiplatelet for ACS Care.

TEROLINT Tablets – Ticagrelor Tablets 90 Mg is an advanced antiplatelet medicine that reversibly blocks the P2Y12 receptor, thereby preventing ADP-induced platelet activation and clot formation. Its reversible action ensures effective platelet inhibition with the added advantage of faster recovery of platelet function compared to conventional agents like clopidogrel, lowering both thrombotic and bleeding risks.

Key Benefits of Ticagrelor Tablets 90 Mg – TEROLINT Tablets
✅ Superior Antiplatelet Efficacy – Provides more rapid and consistent platelet inhibition than clopidogrel.
✅ Reduced Risk of Cardiovascular Events – Lowers the incidence of myocardial infarction, stroke, and stent thrombosis in ACS patients.
✅ Reversible Action – Offers flexibility in managing bleeding risks and perioperative care.
✅ Proven Clinical Evidence – Backed by large-scale trials like PLATO, demonstrating improved survival outcomes.

Recommended By Specialists:
👨‍⚕️ Cardiologists: For patients with acute coronary syndromes (ACS) or post-percutaneous coronary intervention (PCI).
👨‍⚕️ Cardiothoracic Surgeons: In selected cases to prevent stent thrombosis or graft occlusion.
👨‍⚕️ Physicians: For long-term secondary prevention in cardiac patients.

INDICATIONS:
✅ Acute Coronary Syndromes (ACS)
✅ Unstable Angina
✅ Myocardial Infarction (MI)
✅ Prevention of thrombotic complications in ACS patients